Unless otherwise noted, speakers have nothing to disclose.

Moderators

Marc Gerdisch, MD
Disclosure: Artivion: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Atricure: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); CorMatrix: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); DASI: Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Edwards Life Science: Consultant (Ongoing); Zimmer Biomet: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Royalties (Ongoing)

Eric Okum, MD
Disclosure: AtriCure: Consultant (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Presentations

1. Surgical Ablation for Atrial Fibrillation During Mitral Valve Surgery is Associated with Improved Survival and Reduced Stroke Risk in US Veterans
   John Duggan, MD
    
2. Trends in Surgical Ablation at the Time of Cardiac Surgery among Patients with Atrial Fibrillation
   Haley N. Jenkins, MD
    
3. A Novel Prophylactic Left Atrial Ablation in Cardiac Surgery Patients to Prevent POAF; An Initial Experience
   Armin Kiankhooy, MD
   Disclosure: AtriCure: Institutional Research Grant (Ongoing), Speaker/Honoraria (Ongoing)
    
4. Expert Commentary
   James L. Cox, MD
   Disclosure: Adagio Medical: Advisory Board (Ongoing), Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); AtriCure: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Lucid Diagnostics: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); PAVmed: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
    
5. Incidence of acute thrombosis after surgical left atrial appendage occlusion for atrial fibrillation
   Takafumi Inoue, MD, PhD
    
6. Panel Discussion